MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CORT — Corcept Therapeutics Inc.
NasdaqCorcept Therapeutics Inc.
$116.23
+2.21(+1.93%)
- O
- 114.38
- H
- 117.32
- L
- 113.90
- V
- 930.19K
⏱️ End-of-day dataAs of Oct 2, 2026
CORT — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 108,738.00 | 120,495.00 | 125,138.00 | 102,745.00 | 89,819.00 | 127,665.00 |
| Other Short Term Investments | 229,446.00 | 251,657.00 | 296,545.00 | 239,481.00 | 232,944.00 | 255,669.00 |
| Accounts Receivable | 39,072.00 | 59,786.00 | 69,629.00 | 64,567.00 | 61,819.00 | 53,976.00 |
| Inventory | 12,890.00 | 12,868.00 | 12,349.00 | 12,276.00 | 14,368.00 | 12,412.00 |
| Prepaid Assets | 25,095.00 | 28,495.00 | 25,460.00 | 12,172.00 | 10,371.00 | 11,309.00 |
| Other Current Assets | 6,380.00 | 7,102.00 | 5,999.00 | 7,470.00 | 24,866.00 | 6,078.00 |
| Total Current Assets | 426,033.00 | 485,464.00 | 541,130.00 | 443,112.00 | 438,503.00 | 471,602.00 |
| Properties | 10,367.00 | 6,473.00 | 6,870.00 | 7,312.00 | 7,690.00 | 8,013.00 |
| Investments And Advances | 177,261.00 | 160,270.00 | 102,557.00 | 172,775.00 | 248,041.00 | 219,831.00 |
| Other Non Current Assets | 201,220.00 | 184,444.00 | 173,050.00 | 178,523.00 | 152,221.00 | 141,107.00 |
| Total Non Current Assets | 388,848.00 | 351,187.00 | 282,477.00 | 358,610.00 | 407,952.00 | 368,951.00 |
| Total Assets | 814,881.00 | 836,651.00 | 823,607.00 | 801,722.00 | 846,455.00 | 840,553.00 |
| Accounts Payable | 33,306.00 | 40,444.00 | 34,446.00 | 23,525.00 | 27,947.00 | 15,376.00 |
| Accrued Expenses | 47,678.00 | 44,564.00 | 37,240.00 | 36,091.00 | 29,457.00 | 38,794.00 |
| Short Term Debt | 1,627.00 | 1,084.00 | 1,050.00 | 1,017.00 | 984.00 | 829.00 |
| Deferred Revenue | 33,562.00 | 35,679.00 | 53,335.00 | 50,866.00 | 44,232.00 | 41,580.00 |
| Pensions | 20,872.00 | 37,400.00 | 35,284.00 | 26,281.00 | 36,420.00 | 41,731.00 |
| Other Current Liabilities | 12,140.00 | 6,914.00 | 10,910.00 | 6,884.00 | 4,026.00 | 2,272.00 |
| Total Current Liabilities | 149,185.00 | 166,085.00 | 172,265.00 | 144,664.00 | 143,066.00 | 140,773.00 |
| Long Term Debt | 8,010.00 | 5,023.00 | 5,308.00 | 5,588.00 | 5,851.00 | 6,107.00 |
| Provision For Risks And Charges | 15,332.00 | 15,176.00 | 14,132.00 | 15,677.00 | 14,253.00 | 14,084.00 |
| Total Non Current Liabilities | 27,709.00 | 22,761.00 | 19,440.00 | 21,265.00 | 20,104.00 | 20,191.00 |
| Total Liabilities | 176,894.00 | 188,846.00 | 191,705.00 | 165,929.00 | 163,170.00 | 160,964.00 |
| Common Stock | 141.00 | 140.00 | 139.00 | 138.00 | 137.00 | 136.00 |
| Retained Earnings | 611,626.00 | 643,387.00 | 619,099.00 | 599,431.00 | 564,282.00 | 543,735.00 |
| Other Shareholders Equity | 918.00 | 2,264.00 | 2,341.00 | 2,291.00 | 692.00 | -217.00 |
| Total Shareholders Equity | 637,987.00 | 647,805.00 | 631,902.00 | 635,793.00 | 683,285.00 | 679,589.00 |
| Additional Paid In Capital | $1.00M | 968,600.00 | 933,613.00 | 900,864.00 | 862,866.00 | 832,108.00 |
| Treasury Stock | 976,688.00 | 966,586.00 | 923,290.00 | 866,931.00 | 744,692.00 | 696,173.00 |
| Tax Payable | N/A | N/A | N/A | N/A | N/A | 191.00 |